Sodium channel protein type 9 subunit alpha (Nav1.7), Sodium channel protein type 10 subunit alpha (Nav1.8), Sodium channel protein type 11 subunit alpha (Nav1.9) (Nav1.7, Nav1.8, Nav1.9)

Voltage-gated sodium channel subunits Nav1.7, Nav1.8, and Nav1.9 are transmembrane proteins primarily expressed in peripheral sensory neurons such as those in the dorsal root ganglion. These ion channels are critical for the initiation and propagation of action potentials, and each plays a distinct but overlapping role in the transmission of pain signals[2][3][4][5][8]. Nav1.7 operates as a threshold channel, amplifying incoming depolarizations and setting the excitability of nociceptors; dysfunction or mutation in Nav1.7 can lead to severe pain disorders or loss of pain sensation[1][5][9]. Nav1.8 contributes to action potential upstroke, persistent firing in pain fibers, and has a prominent role in inflammatory and neuropathic pain[2][4][8]. Nav1.9 mediates persistent sodium currents near resting membrane potential and is crucial for setting excitability thresholds in small-diameter sensory neurons, particularly involved in cold pain and chronic pain syndromes[2][5][8]. All three channels represent key validated therapeutic targets for novel non-opioid analgesics, though clinical translation has been hindered by significant challenges in achieving safe, selective inhibition without off-target toxicity[2][6][9][10].

Other names

SCN9A (Nav1.7)SCN10A (Nav1.8)SCN11A (Nav1.9)Voltage-gated sodium channel alpha subunit 9/10/11SNS (Nav1.8)NaN (Nav1.9)

Inhibition of sodium influx through voltage-gated sodium channels in sensory neurons, reducing neuronal excitability and blocking pain transmission[2][3][6][10] Allosteric modulation or pore blocking Selective blockade of sodium channel subtypes to reduce peripheral hyperexcitability without affecting central nervous system function